CompletedNot Applicable

Excimer Light in Psoriasis

Egypt40 participantsStarted 2022-03-10

Plain-language summary

The aim of this study is to determine the standard tissue levels of SP and its receptor in lesional skin of psoriasis patients in both developing and stationary stages before and after excimer light therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Type of Psoriasis: plaque psoriasis. * Less than 10% surface area. Exclusion Criteria: * Erythrodermic psoriasis * Pustular psoriasis * Topical treatment for psoriasis for the past 2 weeks. * Systemic retinoids in the last 2 years. * Systemic treatments (including any drugs that affect SP level as Aprepitant) in the last 3 months. * Contraindications to excimer light therapy (history of skin malignancy or precancerous conditions like xeroderma pigmentosum or photosensitivity)

What they're measuring

Excimer laser efficiency in active and stable psoriasis

Timeframe: through study completion, an average of 6 months

Excimer laser efficiency on neurogenic inflammation

Timeframe: through study completion, an average of 6 months

Trial details

NCT IDNCT05283876

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-30

View on ClinicalTrials.gov More Psoriasis trials